Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic db/db mice

INTRODUCTION: Treatment using sodium-glucose cotransporter (SGLT) 2 inhibitor and low-carbohydrate diet (LCD) for obesity and type 2 diabetes are similar in terms of carbohydrate limitation. However, their mechanisms of action differ, and the effects on the body remain unclear. We investigated the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusakabe, Toru, Yokota, Shigefumi, Shimizu, Mika, Inoue, Takayuki, Tanaka, Masashi, Ohue-Kitano, Ryuji, Muranaka, Kazuya, Yamakage, Hajime, Wada, Hiromichi, Hasegawa, Koji, Satoh-Asahara, Noriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473664/
https://www.ncbi.nlm.nih.gov/pubmed/32883687
http://dx.doi.org/10.1136/bmjdrc-2020-001303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473664/
https://www.ncbi.nlm.nih.gov/pubmed/32883687
http://dx.doi.org/10.1136/bmjdrc-2020-001303

Ejemplares similares